Listen to The Lancet Respiratory Medicine
by The Lancet Respiratory Medicine
In conversation with... Anne-Marie Dingemans; Isabelle Opiz; Corinne…
About this podcast
The Lancet Respiratory Medicine publishes a range of article types in respiratory medicine and critical care. These include Original Research, Reviews, Personal Views, Comments, and News articles. Topics include but are not limited to asthma, COPD, tobacco control, critical care, lung cancer, cystic fibrosis, pneumonia, sarcoidosis, mesothelioma, sleep medicine, and respiratory infections.
Episodes
The newest 20 of 171 episodes
- In conversation with... Anne-Marie Dingemans; Isabelle Opiz; Corinne Faivre-Finn · 28 minAnne-Marie Dingemans, Isabelle Opiz, and Corinne Faivre-Finn talk about their multidisciplinary efforts to develop a consensus definition of stage III Non-Small Cell Lung Cancer…
- In conversation with... Anne Holland and Christine McDonald · 12 minAnne Holland and Christine McDonald join Diana Stanley to discuss ambulatory oxygen for treatment of exertional hypoxaemia in pulmonary fibrosis.
- In conversation with... Marion Moseby-Knappe · 8 minMarion Moseby-Knappe talks about a prospective, international, observational biomarker study, within the Targeted Hypothermia versus Normothermia after Out-of-Hospital Cardiac…
- In conversation with... Sailesh Kotecha · 12 minSeries on Prematurity-associated lung disease and a conference session at 4pm GMT on 27/11/25
- In conversation with... Neil Greening and Hnin Aung · 15 minDr Neil Greening and Dr Hnin Aung join Diana Stanley to discuss a new multidimensional prognostic risk stratification model for COPD exacerbations.
- In conversation with... Finn McQuaid and Matthew Saunders · 11 minDr Finn McQuaid and Dr Matthew Saunders join Arianna Colosio to discuss an analytical framework to describe potential causal relationships between climate change and tuberculosis.
- In conversation with...Toby Maher · 9 minToby Maher joins us to discuss results of a randomised, double-blind, placebo-controlled, proof-of-concept trial of ENV-101, an oral inhibitor of the hedgehog signalling pathway…
- In conversation with... Guy Brusselle and Celeste Porsbjerg · 23 minProfessors Guy Brusselle and Celeste Porsbjerg join us to discuss their recent Series papers on asthma, which will be featured in a cross journal project with The Lancet.
- In conversation with... Joan Soriano · 11 minDiana Stanley, Deputy Editor at The Lancet Respiratory Medicine, is joined by Dr Joan Soriano to discuss a new series on the global epidemiology of respiratory disease, exploring…
- In conversation with... Carole Mitnick and Lorenzo Guglielmetti · 19 minCarole Mitnick & Lorenzo Guglielmetti join Ari Colosio, deputy editor of The Lancet Respiratory Medicine, to discuss the ENDTB-Q trial to evaluate the efficacy and safety of a…
- In conversation with... Lorenzo Guglielmetti (in Italian) · 15 minLorenzo Guglielmetti sul trial clinico ENDTB-Q per valutare l’efficacia e la sicurezza di un regime di farmaci per curare la tubercolosi in individui con tubercolosi pre-estesa…
- In conversation with... Laura Garriga-Grimau · 12 minAri Colosio speaks with Dr. Laura Garriga-Grimau about the first multi-country cohort study to describe the clinical features and standards of care for children and young people…
- In conversation with... Marcus J Schultz and Prashant Nasa · 12 minBianca Brandon is joined by Professor Marcus Schultz and Dr Prashant Nasa to discuss their recent Position Paper reporting insights from an international Delphi expert panel on…
- In conversation with... Hjalmar Bouma · 14 minBianca Brandon, Senior Editor at The Lancet Respiratory Medicine, is joined by Professor Hjalmar Bouma to discuss a new review on sepsis in immunocompromised patients, exploring…
- In conversation with... Simon Wolf · 12 minDeputy Editor of The Lancet Respiratory Medicine Ari Colosio discusses the critical findings of a new epidemiological study on pulmonary embolism in children and adolescents with…
- In conversation with... Sergio Harari (in Italian) · 11 minIl Professor Sergio Harari commenta i risultati di un trial clinico di fase 2 volto a valutare l’attivita’ e la sicurezza del farmaco nintedanib come trattamento in pazienti…
- In conversation with... Sergio Harari · 10 minProfessor Sergio Harari joins us to discuss the results of a phase 2 clinical trial evaluating activity and safety of nintedanib in people with lymphangioleiomyomatosis (LAM).
- In conversation with... Robert Kullberg · 12 minDr Robert Kullberg joins us to discuss his Viewpoint on empiric antibiotic therapy for sepsis and the importance of reducing unnecessary use of anti-anaerobic antibiotics.
- In conversation with... Heather Zar · 19 minProfessor Heather Zar joins The Lancet Respiratory Medicine to discuss early-life RSV disease and long-term respiratory health. This topic will be covered in one of four Series…
- In conversation with... James Hull · 11 minProfessor James Hull joins us to discuss his recent Spotlight on protecting the respiratory health of athletes ahead of the Summer Olympics and Paralympics.








